Validity of the conventional indirect methods including Friedewald method for determining serum low-density lipoprotein cholesterol level: Comparison with the direct homogeneous enzymatic analysis

Journal of Occupational Health

Volumn 42, Issue 3, 2000, Pages 130-137

  Nakanishi, Noriyuki ^a   Matsuo, Yoshio ^a   Yoneda, Hideo ^a   Nakamura, Koji ^b   Suzuki, Kenji ^c   Tatara, Kozo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKENAKA CORPORATION   (Japan)

^c Japan Labor and Welfare Association   (Japan)

Author keywords

Direct assay; Friedewald formula; Homogeneous enzymatic method; LDL cholesterol; Screening

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ANALYTIC METHOD; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MALE; MEASUREMENT; NORMAL HUMAN;

EID: 0033919403     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.42.130     Document Type: Article

References (19)

1. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study. JAMA 1986; 256: 2372-2377.
2. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalouedian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256: 2835-2838.
3. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986; ii: 933-936.
4. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in the incidence of coronary heart disease. JAMA 1984; 251: 351-364.
5. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.
6. Brensike JF, Levy RI, Kelsey SF, et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 313-324.
7. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237-1245.
8. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-3240.
9. Expert Panel: Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
11. ) Bachorik PS. Measurement of low density lipoprotein cholesterol. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of lipoprotein testing. Washington, DC: AACC Press, 1997: 145-160.
12. McNamara JR, Cohn JS, Wilson PWF. Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990; 36: 36-42.
13. 2* method. Clin Chem 1998; 44: 1242-1250.
14. Kuba K, Frantz ID Jr. Validity of the Friedewald equation for the estimation of plasma low-density lipoprotein cholesterol (LDL-C) at various concentrations of triglycerides [Abstract]. Clin Chem 1987; 33: 896.
15. Niedbala RS, Schray KJ, Foery R, Clement G. Estimation of low-density lipoprotein by the Friedewald formula and by electrophoresis compared [Letter]. Clin Chem 1985; 31: 1762-1763.
16. Lippi U, Graziani MS, Manzato F, Schinella M. The Friedewald formula: statistical acrobatics? [Letter]. Clin Chem 1986; 32: 909-910.
17. Rao A, Parker AH, El-Sheroni NA, Babelly MM. Calculation of low-density lipoprotein cholesterol with use of triglyceride/ cholesterol ratios in lipoproteins compared with other calculation methods. Clin Chem 1988; 34: 2532-2534.
18. Cohn JS, McNamara JR, Schaefer EJ. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin Chem 1988; 34: 2456-2459.
19. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29: 469-480.